What actually happens is the GLP-1 agonist starts slowing gastric emptying while a large bolus of food is entering the stomach
Many individuals start with GLP-1 medications before considering bariatric surgery later if additional support is needed
Finally, its important to note that making dietary changes to boost GLP-1 release is likely not comparable to the effectiveness of GLP-1 receptor agonist medications like semaglutide
Put them together and the triple combo might achieve the best of all worlds: You get a reduction in food intake, and you can turn the dial up and get a little better energy expenditure, Jonathan Campbell, an obesity researcher at Duke, told me
It reminds me of people who are ashamed of using psychiatric medication, as if happiness should be hard-earned
How PlexusDx Supports a More Personalized Approach PlexusDx's Precision Peptide Genetic Test examines variants in GLP1R, GIPR, MC4R, and FTO genesregions directly implicated in appetite regulation and metabolic response to GLP-1 therapy
